Carmustine Kit
Product Images NDC 71288-126

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 71288-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Car0x 0001 01)

FDA Label Image

Figure (Car0x 0001 02)

This text only provides the name of a pharmaceutical product: Carmustine for Injection, USP. It does not provide any additional information on its usage, indications, side effects or other relevant data. Therefore, a useful description cannot be generated from this text.*

FDA Label Image

Figure (Car0x 0001 03)

FDA Label Image

Figure (Car0x 0001 04)

FDA Label Image

Figure (Car0x 0001 05)

FDA Label Image

Figure (Car0x 0001 06)

FDA Label Image

Figure (Car0x 0001 07)

FDA Label Image

Figure (Car0x 0001 08)

FDA Label Image

Figure (Car0x 0001 09)

FDA Label Image

Vial Label (Car0x 0001 10 V2)

FDA Label Image

Diluent Label (Car0x 0001 11 V2)

FDA Label Image

Carton (Car0x 0001 12 V2)

This is an information sheet for the drug Carmustine indicating necessary precautions to be taken while handling and administering the drug. It provides detailed instructions on how to dissolve the drug and how to store it after reconstitution. Additionally, the sheet informs the reader about the dosage and administration, and the expected stability of the drug after reconstitution. It also provides details on the manufacturer and the container closure.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.